Ajay Piramal
May 19, 2012 at 14:28 | Source: CNBC-TV18
May 16, 2012 at 17:08 | Source: CNBC-TV18
May 16, 2012 at 10:24 | Source: Moneycontrol.com
Apr 16, 2012 at 16:59 | Source: CNBC-TV18
Apr 16, 2012 at 12:56 | Source: Reuters
Apr 11, 2012 at 16:00 | Source: PTI
Videos »
Photos »
/ 
News across the web »
May 24, 2012 at 13:16 | Source: Money Rediff News Report
May 21, 2012 at 01:46 | Source: Business Standard
May 18, 2012 at 10:36 | Source: Economic Times
May 17, 2012 at 16:06 | Source: FirstPost
May 17, 2012 at 13:16 | Source: Business Today
Interact & exchange stock tips & market info »
Related News »
“We have always wanted to have a diversified portfolio of investments not only India but also outside,” Ajay Piramal, chairman of the Indian company, said in an interview. “This is really an acquisition of a business that is a market ...
May 16, 2012 at 15:03 | Source: New York Times
Q&A with chairman of Piramal Healthcare Ajay Piramal, chairman, Piramal Healthcare, looks relaxed and content a day after announcing the acquisition of Decision Resources Group. In a candid interview with Business Standard, he shares his vision for his ...
May 20, 2012 at 18:33 | Source: Business Standard
Sitting in the 10th floor of his corporate headquarters that resembles a mini-Louvre, with its art trove and long corridors, Ajay Gopikrishna Piramal is almost Zen-like in his approach to life and business. One would assume, with $3.8 billion at ...
May 21, 2012 at 04:34 | Source: rediff.com
Mumbai-based Piramal Healthcare, controlled by billionaire Ajay Piramal, has been looking to expand its R&D portfolio after it sold its India formulations business to U.S.-based Abbott Laboratories for $3.7 billion in 2010. Piramal Healthcare ...
May 16, 2012 at 16:29 | Source: Reuters India
At the time, Piramal Healthcare Chairman Ajay Piramal told reporters the company expects a 17%-20% annual return from its investment in Vodafone. Vodafone sold the stake to Piramal Healthcare to likely comply with local rules that don't allow foreign firms ...
May 23, 2012 at 07:52 | Source: 4-traders (press release)
Commenting on the acquisition, Piramal Healthcare chairman Ajay Piramal said, "The global healthcare industry is facing several challenges including rising research costs, lower drug approval rates, mounting regulatory pressures and increasing complex ...
May 17, 2012 at 08:35 | Source: in.news.yahoo.com
Commenting on the development, Piramal Healthcare Chairman Ajay Piramal said: “The need for specialist information is critical and the demand is growing. DRG’s portfolio of products is widely regarded as the gold standard of information.” He further ...
May 16, 2012 at 07:32 | Source: firstpost.com
Mumbai-based Piramal Healthcare, controlled by billionaire Ajay Piramal, has been looking to expand its R&D portfolio after it sold its India formulations business to US-based Abbott Laboratories for $3.7 billion in 2010. Piramal Healthcare aims to close ...
May 16, 2012 at 15:53 | Source: Deccan Herald
Commenting on the acquisition, Chairman Ajay Piramal said, "The global healthcare industry is facing several challenges including rising research costs, lower drug approval rates, mounting regulatory pressures and increasingly complex reimbursement models.
May 16, 2012 at 06:20 | Source: RTT News
Engineering is hardly the only sector that is disillusioned with the Indian business climate: Ajay Piramal, chairman of Piramal Healthcare Ltd., told The Wall Street Journal this week that part of the reason the company is paying $635 million ...
May 18, 2012 at 03:26 | Source: Wall Street Journal